Acadia Pharmaceuticals Stock Price

-0.77 (-3.58%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 3,055,519
Bid Price 20.68
Ask Price 21.50
News -
Day High 22.05


52 Week Range


Day Low 20.935
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.77 -3.58% 20.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
21.385 20.935 22.05 21.18 21.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,997 3,055,519 $ 21.46 $ 65,566,528 - 15.6792 - 54.5792
Last Trade Time Type Quantity Stock Price Currency
18:14:48 formt 100 $ 20.72 USD


Draw Mode:

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.33B 160.76M 99.26M $ 441.76M $ -155.98M -1.80 -18.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -3.27k 0.40%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week21.85523.0720.8921.781,524,975-1.14-5.19%
1 Month24.1725.0920.8922.801,210,905-3.45-14.27%
3 Months18.2027.1917.8422.021,688,5402.5213.85%
6 Months24.2127.1915.679220.081,478,186-3.49-14.42%
1 Year53.6554.579215.679224.081,784,028-32.93-61.38%
3 Years20.8758.7215.679233.361,525,329-0.15-0.72%
5 Years31.0258.7212.7728.851,774,787-10.30-33.2%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.